Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 225.00
+1.00 (0.45%)
Jun 4, 2026, 9:30 AM CET
Medistim ASA Market Cap
Medistim ASA has a market cap or net worth of 4.1 billion as of June 3, 2026. Its market cap has increased by 9.03% in one year.
Market Cap
4.10B
Enterprise Value
3.92B
Revenue
719.89M
Ranking
n/a
PE Ratio
26.23
Stock Price
225.00
Market Cap Chart
Since May 28, 2004, Medistim ASA's market cap has increased from 40.53M to 4.10B, an increase of 10,010.88%. That is a compound annual growth rate of 23.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 4.10B | -13.47% |
| Dec 30, 2025 | 4.74B | 72.95% |
| Dec 30, 2024 | 2.74B | -30.01% |
| Dec 29, 2023 | 3.91B | -7.22% |
| Dec 30, 2022 | 4.22B | -37.01% |
| Dec 30, 2021 | 6.69B | 47.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 2.06B |
| Circio Holding ASA | 2.03B |
| Photocure ASA | 1.61B |
| Thor Medical ASA | 1.58B |
| Nykode Therapeutics AS | 1.10B |
| ArcticZymes Technologies ASA | 1.06B |
| Vistin Pharma ASA | 909.06M |
| Lytix Biopharma ASA | 769.00M |